You are here: Home News mesothelioma 2007
  • Increase font size
  • Default font size
  • Decrease font size
Search

mesothelioma

Mesothelioma News 07

Title Filter     Display # 
# Article Title
1 FDA Designates Onconase (Ranpirnase) As Orphan Drug for Treatment of Malignant Mesothelioma
2 NYU Study Validates Use Of MESOMARK Test For Monitoring Mesothelioma
3 Hyperthermia Enhances Effectiveness of Onconase
4 Further EPA Testing at Alviso Superfund Site
5 Onconase (Ranpirnase) Could be Chemopreventive Agent in Mesothelioma
6 Pathway for Treatment of Malignant Pleural Mesothelioma
7 Data Affirm Benefit of Alimta (pemetrexed)
8 New diagnostic tool for mesothelioma to be developed
9 Alfacell Awkward Wait
10 Alfacell Updates Progress of Phase III Trial
11 US Occupational Injury Rates Lower
12 More Details Emerge on Minnesota Miners with Mesothelioma
13 W.R. Grace
14 Iron Range Studies Could be Compromised by Lack of Funding
15 New Technology For Cancer Screening Listens For The Signs Of Cancer
16 Mining Company Supports Iron Range Mesothelioma Study
17 Nanocell delivers a toxic double whammy to tumors.
18 Use of kinase inhibitors in cancer therapy
19 Proton therapy for mesothelioma treatment
20 Owens Corning to emerge from bankruptcy
21 Pleural Effusions
22 PPG Tries to Dodge Financial Bullet
23 National Cancer Institute's Cancer 2015 program
24 FDA Approves MESOMARK Assay for the Management of Mesothelioma Patients
25 Bloomberg Accepts 9/11 Health Panel's Findings - Mesothelioma Web
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2